On October 21, Aleksey Ryzhyi, Director of the Department of Information Technology at NANOLEK, took part in the Digital Champions. Digitalization as a Source of Rapid Growth for High-Tech Companies round table as part of the 8th Open Innovations Moscow International Forum.
Digital technologies have burst onto the Russian business scene, but at the same time, not all companies are hurrying to join the digital race. During the round table, the experts discussed the Russian companies' need for digital transformation, the justification for expending resources to introduce modern technologies into business processes, and the relevance of process digitalization in various sectors of the economy.
Representatives of fast-growing technology companies shared their implementation experience, talked about what digital technologies they use in their work, described the pros and cons of purchasing ready-made solutions vs. developing their own, and presented cases that evaluated the effectiveness of digital technologies in promoting business economic growth.
Aleksey Ryzhyi: “Recently, NANOLEK has approved an ambitious five-year company development strategy. Within it, IT department specialists developed a strategy for a transition from digital optimization (improving the performance of current processes, improving user experience) to digital transformation (new products and value streams, new business models). We combined plans for both traditional IT activities (target SLA, updating infrastructure, finalizing software), and in terms of project management methods and tools, preparing business partners in our areas, developing a data-driven culture and plans for work with startups.
When entering the project, we always prepare a justification for its necessity and a list of goals whose achievement should lead to specific effects. We are confident that such an approach to the implementation of classic IT projects while developing a new culture of dealing with information by each employee will help maintain the company's dynamic development and create a flexible pharmaceutical company capable of rapid changes.”
